Effect of 1-week treatment with erythropoietin on the vascular endothelial function in anaesthetized rabbits.

作者: Katsuhiko Noguchi , Satoshi Yamashiro , Toshihiro Matsuzaki , Mayuko Sakanashi , Junko Nakasone

DOI: 10.1038/SJ.BJP.0704083

关键词:

摘要: Chronic administration of erythropoietin (EPO) is often associated with hypertension in animals and humans. The aim this study was to estimate whether 1-week treatment EPO can affect the vascular endothelial function. Rabbits were given (400 iu kg−1 s.c.) or saline each other day for 1 week. Hypotensive responses intravenously acetylcholine (ACh), endothelium-independent nitric oxide donors (NOC7, nitroprusside nitroglycerin) prostaglandin I2 tested before after NG-nitro-L-arginine methyl ester (L-NAME), a specific synthase inhibitor, under pentobarbitone anaesthesia. Blood haemoglobin concentration group significantly higher than that control group, whereas baseline values aortic pressure, heart rate femoral resistance similar. dose ACh (172 ng kg−1) requiring 15 mmHg hypotension from apparently (55 ng kg−1) group. On contrary, hypotensive NOC7, nitroprusside, nitroglycerin comparable between two groups. extent ACh-induced did not correlate concentration. L-NAME inhibited vasodilating response but group. In another set rabbits, same also decreased carbachol, bradykinin substance P besides as compared group. These results indicate selectively attenuates depressor endothelium-dependent vasodilators anaesthetized most likely due inhibition synthase. Keywords: Erythropoietin, acetylcholine, haemoglobin, synthase, vasodilator Introduction Erythropoietin (EPO), which glycoprotein hormone secreted primarily kidney lowered blood O2 availability hypoxia, haemorrhage anaemia, acts on erythroid progenitor cells bone marrow, then increases peripheral supply by promoting their proliferation differentiation (Jelkmann, 1992). Medication has gained wide acceptance anaemia chronic renal failure. Development worsening generally considered serious adverse effect (Raine, 1988). Hypertension usually occurs within several weeks months onset accompanied increased haematocrit (Buckner et al., 1990). EPO-induced with, to, an increase resistance, been explained viscosity 1988; Schaefer 1988), loss hypoxia-induced vasodilation (Neff 1971). In addition, (Hb) circulation may theoretically augment trapping (NO), endogenous vasodilator (Martin & Moncada, However, these proposed explanations mechanism remain yet controversial. Recently, it shown receptors are found only endothelium (Anagnostou 1994; Yamaji 1996), reportedly causes acceleration migration 1990) angiogenesis (Carlini 1995b), endothelin-1 release vitro 1993; Bode Boger 1996). known play essential role regulating tone through generation potent vasoactive substances such NO and/or I2. Indeed, impaired suggested causative experimentally hypertensive rats (Hayakawa 1993) normotensive subjects familial history (Taddei Therefore, seems important examine responsiveness endothelium-derived NO. Thus, conducted repeated cause dysfunction. function vivo assessed comparing P, 3-(2-hydroxy-1-methylethyl-2-nitrosohydrazino)-N-methyl-1-propanamine (NOC7), sodium addition rabbits received its vehicle.

参考文章(51)
R. G. G. Andersson, J. Ahlner, K. Torfgard, K. L. Axelsson, ORGANIC NITRATE ESTERS : CLINICAL USE AND MECHANISMS OF ACTIONS Pharmacological Reviews. ,vol. 43, pp. 351- 423 ,(1991)
Frederick S. Buckner, Joseph W. Eschbach, N. Rebecca Haley, Robert C. Davidson, John W. Adamson, Hypertension following erythropoietin therapy in anemic hemodialysis patients. American Journal of Hypertension. ,vol. 3, pp. 947- 955 ,(1990) , 10.1093/AJH/3.12.947
R M Palmer, S Moncada, E A Higgs, NITRIC OXIDE: PHYSIOLOGY, PATHOPHYSIOLOGY, AND PHARMACOLOGY Pharmacological Reviews. ,vol. 43, pp. 109- 142 ,(1991)
Hui Dong, Gareth J. Waldron, Denise Galipeau, William C. Cole, Christopher R. Triggle, NO/PGI2‐independent vasorelaxation and the cytochrome P450 pathway in rabbit carotid artery British Journal of Pharmacology. ,vol. 120, pp. 695- 701 ,(1997) , 10.1038/SJ.BJP.0700945
R. Joannides, E. Bakkali, F. Le Roy, O. Rivault, M. Godin, N. Moore, J. Fillastre, C. Thuillez, Altered flow-dependent vasodilatation of conduit arteries in maintenance haemodialysis. Nephrology Dialysis Transplantation. ,vol. 12, pp. 2623- 2628 ,(1997) , 10.1093/NDT/12.12.2623
Raul G. Carlini, Alvaro A. Reyes, Marcos Rothstein, Recombinant human erythropoietin stimulates angiogenesis in vitro. Kidney International. ,vol. 47, pp. 740- 745 ,(1995) , 10.1038/KI.1995.113
Tetsu HOZUMI, Hiroyasu FUKUTA, Hikaru SUZUKI, Comparison of the relaxing actions of acetylcholine and substance P in smooth muscle of the guinea-pig aorta. Journal of Smooth Muscle Research. ,vol. 33, pp. 67- 77 ,(1997) , 10.1540/JSMR.33.67
S. Moncada, D. D. Rees, R. Schulz, R. M. Palmer, Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 88, pp. 2166- 2170 ,(1991) , 10.1073/PNAS.88.6.2166
Steffen-Sebastian Bolz, Cor De Wit, Ulrich Pohl, Endothelium-derived hyperpolarizing factor but not NO reduces smooth muscle Ca2+ during acetylcholine-induced dilation of microvessels British Journal of Pharmacology. ,vol. 128, pp. 124- 134 ,(1999) , 10.1038/SJ.BJP.0702775